
Bo Xu
Latest contributions
Embrace the innovation in PCI and TAVR: Robocath R-One vascular robot for PCI in China, MicroPort Firehawk TES stent, and VitaFlow valve
18 May 2022 – From EuroPCR 2022
The objective of this EuroPCR 2022 session is to highlight MicroPort's innovation portfolio in 3 different fields: learn more about the clinical performance of Firehawk Family stent in STEMI patients evaluated by imaging tools, the features and benefits of PCI robot R-ONE and first clinical trial updates in China,...

EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary physiology: DECISION QFR, INOCA, and PROPHET-FFR
17 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in coronary physiology! Angiography-derived coronary microcirculatory assessment in INOCA patients, Heart Team decision-making based on angiography-derived FFR: DECISION QFR, and safety and efficacy of post-PCI physiological assessment: PROPHET-FFR.

EuroPCR 2021 Hotlines / Late-Breaking Trials: MAGSTEMI, France ABSORB, FUTURE-II, STRATEGY-IT, AIDA, and PRAGUE 22
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in BRS/BVS:
- Magnesium-based Bioresorbable Scaffold in STEMI: 2 years results
- France Absorb registry: final five years follow-up
- A randomized trial of thinner-strut sirolimus-eluting BRS in de novo lesions
- Three-year follow-up of the prospective bvs stemi strategy-it study
- Final five-year results of AIDA trial
- Bioresorbable...

Antegrade CTO PCI with wire escalation - Session with LIVE demonstration
20 May 2021 – From EuroPCR 2021
Watch this session if you want to discuss how to plan and guide a CTO PCI, to learn how to select the most appropriate wires and microcatheters, and to appraise how to apply antegrade and retrograde techniques in a structured manner.
This session was originally presented during...

Bi-directional approach in a complex CTO - Session with LIVE demonstration
20 May 2021 – From EuroPCR 2021
Watch this session if you want to discuss how to plan and guide a CTO PCI, to learn how to select the most appropriate wires and microcatheters and to appraise how to apply antegrade and retrograde techniques in a structured manner.
This session was originally presented during...

Leading with evidence, latest clinical outcomes update for Firesorb, Firehawk and VitaFlow
19 May 2021 – From EuroPCR 2021
Watch this session presented by Alexandra Lansky, Andreas Baumbauch, Junbo Ge and Bo Xu in order to learn about the one-year results from a pivotal RCT (FUTURE II), the four-year results from TARGET AC, and the four-year results from VitaFlow transcatheter aortic valve system in patients with severe aortic...

The role of physiology, CT and intracoronary imaging for the management of multivessel disease (Part 2)
19 May 2021 – From EuroPCR 2021
Watch this session if you want to understand the role of invasive physiology in planning, guiding and evaluating your PCI strategy in MVD, to appreciate the role of intravascular imaging in the optimisation of PCI in such patients and to explore the expanding role of CT...

The role of physiology, CT and intracoronary imaging for the management of multivessel disease (Part 1)
19 May 2021 – From EuroPCR 2021
Watch this session if you want to understand the role of invasive physiology in planning, guiding and evaluating your PCI strategy in MVD, to appreciate the role of intravascular imaging in the optimisation of PCI in such patients and to explore the expanding role of CT...

One-year results from the FUTURE-II trial
19 May 2021 – From EuroPCR 2021
This LBT session, which was originally presented during EuroPCR 2021, deals with the FUTURE-II study on the new generation of bioresorbable scaffolds, providing comparative safety and efficacy evidence of the thinner-strut PLLA-based BRS in the treatment of patients with noncomplex coronary lesions.

PCR e-Course 2020 Late-Breaking Trials - part 2
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Late-Breaking Trials presented during the PCR e-Course 2020 and see how they might have an impact on your practice:
- 2-year safety of revascularisation deferral based on iFR or FFR
- CABG and PCI in patients with CTO and multivessel disease
- Routine revascularisation vs. medical therapy

Prevention and management of iatrogenic coronary dissection - Part 1
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about how to prevent and manage iatrogenic coronary dissection, with compelling clinical cases such as an iatrogenic dissection of trifurcated left main, an aorto-ostial dissection in heavily calcified right coronary artery, and more!

Bioresorbable scaffold: new data, new hope?
22 May 2019 – From EuroPCR 2019
Consult this session on bioresorbable scaffold (BRS) to learn about new data and clinical outcomes: FAMTOM II trial, BIOSOLVE-IV registry, and more!

CTO intervention in patients with prior CABG
22 May 2019 – From EuroPCR 2019
Consult this session to learn all about CTO intervention in patients with prior coronary artery bypass graft (CABG): challenges, tools, techniques, and more!

Trial updates and registries - Clinical outcomes after DES implantation: impact of strut thickness
22 May 2019 – From EuroPCR 2019
Consult this session to learn all about the latest trial updates and registries regarding the clinical outcomes after DES implantation, and their impact on your daily practice.
